Allison Michele Stickles , MD,PhD

Dr. Stickles is a hospital medicine physician with training in both Internal Medicine and Pediatrics. She enjoys complex care and is passionate about helping those with limited resources. Her past research has focused on drug discovery for neglected tropical diseases and clinical trial work for malaria and HIV.
 

BA: University of Rochester Rochester, NY, 2007 (Psychology )

BS: University of Rochester Rochester, NY, 2007 (Neuroscience)

MS: University of Rochester Rochester, NY, 2008 (Neuroscience)

MD: Oregon Health & Science University Portland, OR, 2016

PhD: Oregon Health & Science University Portland, OR, 2014 (Chemical Biology and Parasitology)

Residency: University of Cincinnati Cincinnati, OH, 2020 (Internal Medicine and Pediatrics)

American Board of Internal Medicine (Certification Date: 08-28-2020 )

American Board of Pediatrics (Certification Date: 10-14-2021 )

Internal Medicine

Internal Medicine

Pediatrics

Peer Reviewed Publications

Stickles, Allison M; Smilkstein, Martin J; Morrisey, Joanne M; Li, Yuexin; Forquer, Isaac P; Kelly, Jane X; Pou, Sovitj; Winter, Rolf W; Nilsen, Aaron; Vaidya, Akhil B; Riscoe, Michael K (2016. ) Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria.Antimicrobial agents and chemotherapy, , 60 (8 ) ,4853-9 More Information

Miley, Galen P; Pou, Sovitj; Winter, Rolf; Nilsen, Aaron; Li, Yuexin; Kelly, Jane X; Stickles, Allison M; Mather, Michael W; Forquer, Isaac P; Pershing, April M; White, Karen; Shackleford, David; Saunders, Jessica; Chen, Gong; Ting, Li-Min; Kim, Kami; Zakharov, Lev N; Donini, Cristina; Burrows, Jeremy N; Vaidya, Akhil B; Charman, Susan A; Riscoe, Michael K (2015. ) ELQ-300 prodrugs for enhanced delivery and single-dose cure of malaria.Antimicrobial agents and chemotherapy, , 59 (9 ) ,5555-60 More Information

Stickles, Allison M; Ting, Li-Min; Morrisey, Joanne M; Li, Yuexin; Mather, Michael W; Meermeier, Erin; Pershing, April M; Forquer, Isaac P; Miley, Galen P; Pou, Sovitj; Winter, Rolf W; Hinrichs, David J; Kelly, Jane X; Kim, Kami; Vaidya, Akhil B; Riscoe, Michael K; Nilsen, Aaron (2015. ) Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy.The American journal of tropical medicine and hygiene, , 92 (6 ) ,1195-201 More Information

Stickles, Allison M; de Almeida, Mariana Justino; Morrisey, Joanne M; Sheridan, Kayla A; Forquer, Isaac P; Nilsen, Aaron; Winter, Rolf W; Burrows, Jeremy N; Fidock, David A; Vaidya, Akhil B; Riscoe, Michael K (2015. ) Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparum.Antimicrobial agents and chemotherapy, , 59 (4 ) ,1977-82 More Information

Nilsen, Aaron; Miley, Galen P; Forquer, Isaac P; Mather, Michael W; Katneni, Kasiram; Li, Yuexin; Pou, Sovitj; Pershing, April M; Stickles, Allison M; Ryan, Eileen; Kelly, Jane Xu; Doggett, J Stone; White, Karen L; Hinrichs, David J; Winter, Rolf W; Charman, Susan A; Zakharov, Lev N; Bathurst, Ian; Burrows, Jeremy N; Vaidya, Akhil B; Riscoe, Michael K (2014. ) Discovery, synthesis, and optimization of antimalarial 4(1H)-quinolone-3-diarylethers.Journal of medicinal chemistry, , 57 (9 ) ,3818-34 More Information

Invited Presentations

Stickles, A.M., Smilkstein, M.J., Morrisey, J.M., Li, Y., Forquer, I.P., Kelly, J.X., Winter, R.W., Nilsen, A., Vaidya, A.B., Riscoe, M.K (01-2016. ) Atovaquone and ELQ-300 combination therapy: A novel dual-site inhibition strategy for malaria .Drug Discovery for Parasitic Diseases Keystone Conference, Tahoe City, CA. Level:International

Stickles, A.M., Forquer, I.P., Nilsen, A., Li, Y., Kelly, J.X., Winter, R.W., Riscoe, M.K (05-2015. ) Dual-site inhibition of cytochrome bc1 as a strategy for antimalarial combination therapy: an in vivo assessment of atovaquone and ELQ-300 .Seattle Parasitology Meeting, Seattle, WA. Level:Regional

Stickles, A.M., Forquer, I.P, Nilsen, A., Li, Y., Kelly, J.X., Winter, R.W., Riscoe, M.K (11-2013. ) Balancing potency and toxicity: optimization of ELQ-400 for single-dose cures in malaria .American Society of Tropical Medicine and Hygiene Annual Meeting, Washington DC. Level:National

Stickles, A.M., Nilsen, A., Forquer, I.P., Li, Y., Kelly, J.X., Winter, R.W., Riscoe, M.K (06-2013. ) Balancing potency and toxicity: optimization of ELQ-400 for single-dose antimalarial therapy .Seattle Parasitology Meeting, Seattle, WA. Level:Regional

Poster Presentations

Stickles, A.M., Forquer, I.P., Nilsen, A., Li, Y., Kelly, J.X., Winter, R.W., Riscoe, M.K (02-2014. ) Qo vs. Qi inhibition of cytochrome bc1 produces distinct biological responses in Plasmodium .The Science of Malaria Eradication Keystone Symposia, Merida, Mexico. . Level:International

Stickles, A.M., Morrisey, J.M., Justino de Almeida, M., Nilsen, A., Mather, M.W., Vaidya, A.B., Fidock, D.A., Riscoe, M.K (11-2013. ) Characterization of the cytochrome bc1 Qi site as a novel antimalarial target .American Society of Tropical Medicine and Hygiene Annual Meeting, Washington DC. . Level:National

Stickles, A.M., Morrisey, J.M., Justino de Almeida, M., Forquer, I.P., Nilsen, A., Li, Y., Kelly, J.X., Winter, R.W., Fidock, D.A., Vaidya, A.B., Riscoe, M.K (09-2013. ) Mapping mitochondrial inhibition: using chemical structure to understand host toxicity .Molecular Parasitology Meeting, Woods Hole, MA. . Level:National

Stickles, A.M., Forquer, I.P., Nilsen, A., Riscoe, M.K (04-2013. ) Biological activity and derivatization of 4(1H)-quinolone ester antimalarials .Western Regional Global Health Conference, Portland, OR. . Level:Regional

AOA Medical Honor Society

2015 Infectious Disease Society of America: Medical Scholar Award

2012 Biology of Parasitism Course: International Representative

2016: National Med Peds Resident Association

2015: Infectious Disease Society of America

2013: American Society of Tropical Medicine and Hygiene

2010: American Physician Scientist Association